111: Nanoparticles in Neurodegenerative Disease Treatment
About this episode
Buck interviews Mark Mortenson and Rob Etherington from Clene Nanomedicine, discussing their innovative approach to treating neurodegenerative diseases using clean surface nanocrystals. They delve into the science behind nanoparticles, their role in enhancing mitochondrial function, and the mechanisms of neurorepair. They also cover clinical applications, safety considerations, and the challenges in bringing their nanomedicine to market.
Get every episode summarized
Each time Longevity Roadmap publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Longevity Roadmap
169: Protein Folding Errors Contribute to Aging and Disease
Longevity Roadmap
168: Best of 2025
Longevity Roadmap
167: Why Bats Don't Age and Why You Should Care with Dr. Emma Teeling
Longevity Roadmap
166: BioXcellerator - The Cutting Edge of Stem Cell Therapy
Longevity Roadmap